Johnson Matthey PLC (LON:JMAT) has been given an average recommendation of “Buy” by the nine research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is GBX 3,860 ($50.28).

Several brokerages have recently weighed in on JMAT. Deutsche Bank increased their price objective on shares of Johnson Matthey from GBX 3,570 ($46.50) to GBX 4,500 ($58.62) and gave the stock a “buy” rating in a report on Friday, June 15th. Morgan Stanley reiterated an “overweight” rating and set a GBX 3,900 ($50.80) price objective on shares of Johnson Matthey in a report on Monday, June 4th. Liberum Capital reiterated a “buy” rating and set a GBX 4,000 ($52.10) price objective on shares of Johnson Matthey in a report on Thursday, July 26th. Berenberg Bank reiterated a “buy” rating and set a GBX 4,300 ($56.01) price objective on shares of Johnson Matthey in a report on Tuesday, July 3rd. Finally, Credit Suisse Group reiterated an “outperform” rating on shares of Johnson Matthey in a report on Thursday, August 23rd.

Shares of JMAT stock traded down GBX 26 ($0.34) during trading hours on Friday, hitting GBX 3,625 ($47.22). 146,977 shares of the company were exchanged, compared to its average volume of 691,012. Johnson Matthey has a 1 year low of GBX 2,681 ($34.92) and a 1 year high of GBX 3,511 ($45.73).

In related news, insider Annette Kelleher sold 985 shares of the stock in a transaction that occurred on Wednesday, August 1st. The shares were sold at an average price of GBX 3,709 ($48.31), for a total transaction of £36,533.65 ($47,588.45). Also, insider John Walker bought 12 shares of the company’s stock in a transaction that occurred on Wednesday, September 19th. The shares were acquired at an average cost of GBX 3,579 ($46.62) per share, with a total value of £429.48 ($559.44). In the last three months, insiders have purchased 36 shares of company stock valued at $130,944.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Read More: Closed-End Mutual Funds

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.